Showing results (181-190 of 433) with videos related to

Sort By:
Pageof 44
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CTJason Callahan, Michael S Hofman, Shankar Siva, et al.
Anti-Cancer Drugs|April 18, 2008
Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinomaSarah-Jane Dawson, Nelly Marmy Conus, Guy C Toner, et al.
Heart, Lung & Circulation|August 7, 2019
Early Outcomes of Surgery for Carcinoid Heart DiseaseMatthew S Yong, Grace Kong, Prakash Ludhani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2014
Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung CancerAntoine Leimgruber, Andreas Möller, Sarah J Everitt, et al.
Biomedical Physics & Engineering Express|December 15, 2023
Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [18F]FDG PET-CT imagesGeorgios Krokos, Tejas Kotwal, Afnan Malaih, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 2, 2015
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)Thomas Bengtsson, Sandra M Sanabria-Bohorquez, Timothy J McCarthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor modelNicolas Aide, Kathryn Kinross, Carleen Cullinane, et al.
Brain : a Journal of Neurology|September 9, 2006
The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomyAnita B Vinton, Ross Carne, Rodney J Hicks, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 14, 2021
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinomaLuke S McLean, Karda Cavanagh, Rodney J Hicks, et al.
Pageof 44